Sebastian Lobentanzer

Principal Investigator

Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit
Country flagGermany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (13)

Year:

2026

Artificial intelligence (AI) is driving innovation in clinical pharmacology and translational science with tools to advance drug development, clinical trials, and patient care. This review summarizes the key takeaways from the AI preconference at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) 2024 Annual Meeting in Colorado Springs, where experts from academia, industry, and regulatory bodies discussed how AI is streamlining drug discovery, dosing strategies, outcome assessment, and patient care. The theme of the preconference was centered around how AI can empower clinical pharmacologists and translational researchers to make informed decisions and translate research findings into practice. The preconference also looked at the impact of large language models in biomedical research and how these tools are democratizing data analysis and empowering researchers. The application of explainable AI in predicting drug efficacy and safety, and the ethical considerations that should be applied when integrating AI into clinical and biomedical research were also touched upon. By sharing these diverse perspectives and real‐world examples, this review shows how AI can be used in clinical pharmacology and translational science to bring efficiency and accelerate drug discovery and development to address patients' unmet clinical needs.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Large language models (LLMs) face reliability challenges stemming from hallucinations and insufficient access to validated scientific resources. Existing solutions are often fragmented and limited to specific applications, hindering broader adoption and interoperability. Here, we present Biomedical Context for Artificial Intelligence (BioContextAI), an open-source initiative centered on Model Context Protocol (MCP) servers to address these limitations. BioContextAI provides a community-oriented registry for discovering domain-specific MCP servers and a proof-of-concept server implementation that integrates widely-used biomedical knowledgebases. By enabling standardized access to validated scientific knowledge, BioContextAI aims to facilitate the development of composable agentic systems for biomedical research. Together, this work contributes to an emerging ecosystem of community-driven approaches for expanding the capabilities and reliability of biomedical AI systems.

Year:

2025

Join us for a live panel discussion as part of our ongoing webinar series, Large Language Models and their applications in bioinformatics. This interactive QA session offers attendees the opportunity to engage with speakers from the series, ask new questions, and revisit key discussions.

Year:

2025

This project seeks to enhance the ELIXIR Research Software Ecosystem (RSEc) by increasing the findability, accessibility, interoperability, and reusability (FAIR principles) of Bioconductor’s extensive collection of over 2,000 bioinformatics packages. By aligning Bioconductor metadata with the EDAM ontology and integrating detailed package descriptions into the _bio.tools_ registry, we aim to improve the discoverability and usability of bioinformatics analysis tools. Short-term goals include mapping Bioconductor’s biocViews controlled vocabulary to EDAM concepts, developing a set of manually annotated “gold standard” packages, and evaluating tools for automated EDAM concept suggestions. Long-term, we intend to expand EDAM coverage across Bioconductor, phase out biocViews, and implement automated synchronisation with _bio.tools_. This initiative fosters collaboration between Bioconductor and ELIXIR, establishing a foundation for sustainable software management in European bioinformatics.Key results from the ELIXIR BioHackathon 2024 week include substantial progress in mapping the biocViews vocabulary to EDAM concepts, initiating the curation of a reference set of packages with manual annotations, integrating Bioconductor metadata into the ELIXIR Research Software Ecosystem (RSEc) with automated updates, and prototyping a tool for automated EDAM concept suggestions. Together, these achievements establish a strong foundation for further integration and refinement.

Year:

2025

LLMs are the biggest new industry on our planet. Considering the amount of research and investments in the field, large and rapid progress is expected for the coming decade. However, to make use of the technology, we need to have a solid grasp on its technical as well as infrastructural aspects. LLM deployment entails a layered tech stack: the LLM itself, deployment (use of services or self-hosting), technical guardrails (instruction, fine-tuning), auxiliary technologies (retrieval-augmented generation, knowledge integration), and end-user accessibility (programming APIs, user interfaces). Applying the latest knowledge about LLMs in a robust and trustworthy way is an operative challenge despite the large improvements we already see in the wider field. In this webinar, we will talk about the LLM stack with a focus on open-source frameworks that facilitate deployment at various levels. The base layer are the deployment frameworks themselves (e.g., Ollama), as well as harmonising APIs for open-source LLMs by commercial providers. The second layer are frameworks for LLM integration into user systems, as championed by LangChain. The third layer are domain-specific frameworks such as our own development, BioChatter, which also reaches over into the fourth layer, dedicated user interfaces. To future-proof our approach to this powerful technology, it is imperative to avoid redundancies; in order to not reinvent the wheel, we need to be aware of which problems are solved and which are worth tackling. We will discuss a flexible framework for using open-source technologies at various stages of project maturity, from proof of concept to service provision. Finally, we will discuss the scope of LLM application: what can they safely be used for, and which applications are still out of reach?

Year:

2025

The workshop on connecting Knowledge Graphs (KGs) with BioChatter convened experts from biology, computer science, and bioinformatics to tackle challenges in integrating and accessing dispersed datasets in plant sciences. The goal was to create user-friendly interfaces for querying these datasets using natural language, bypassing the need for expertise in semantic technologies or query languages like SPARQL or Cypher.Key use cases included the BrAPI project, which aimed to simplify data retrieval from plant research datasets. While BioChatter effectively generated simple API queries, complex multi-step queries posed challenges, suggesting that programmatic approaches are better suited for such tasks. Integrating BrAPI with BioCypher enabled successful querying of KGs for questions like identifying studies involving specific plant varieties.The RDF adapter use case focused on enhancing the Plant Phenotyping Experiment Ontology (PPEO) by converting it into a BioCypher-compatible KG, thereby improving data interoperability and enabling LLMs to generate context-aware responses. The Mobile Element Knowledge Graph use case explored the relationship between transposable elements and gene regulation networks, utilizing BioChatter to assist users unfamiliar with Cypher.The Stress Knowledge Map (SKM) use case integrated a highly curated model of plant stress signaling with BioCypher and BioChatter, allowing natural language queries and improving access to complex biological data. The Chem and Plant KG use case aimed to integrate diverse scientific resources into a unified KG, enhancing data interoperability and accessibility.Challenges included the need for human-readable concepts within KGs to improve LLM interaction and aligning LLMs with user demands. Future work will focus on refining KG schemas, improving LLM integration, and expanding documentation to support broader adoption and utility in scientific research. The workshop highlighted the potential of combining KGs with LLMs to enhance data accessibility and drive new insights in biological and agricultural sciences.

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Collaborators (28)

Kourosh Saeb-Parsy

Reader

University of Cambridge

UNITED KINGDOM
View details

Dagmar Waltemath

Professor

Universitätsmedizin Greifswald

GERMANY
View details

Elias Farr

Wellcome Sanger Institute

UNITED KINGDOM
View details

Ruoyan Li

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Ulf Panzer

University Medical Center Hamburg-Eppendorf

GERMANY
View details

Yuanfang Guan

University of Michigan

UNITED STATES
View details

Egon Willighagen

Universitair Docent / Assistant Professor

University of Maastricht

NETHERLANDS
View details

Christopher J Stewart

Professor of Human Microbiome Research

Newcastle University

UNITED KINGDOM
View details

Julio Saez-Rodriguez

Head of Research

European Bioinformatics Institute

UNITED KINGDOM
View details

Sarah Teichmann

University of Cambridge

UNITED KINGDOM
View details

Victor Puelles

VIP, Professor

Aarhus University

DENMARK
View details

Lionel Christiaen

Director, Group leader

New York University

UNITED STATES
View details

Taru Muranen

University of Helsinki

FINLAND
View details

Frode Jahnsen

Professor at University of Oslo

University of Oslo

NORWAY
View details

Melissa Harrison

Group Team Leader

European Bioinformatics Institute

UNITED KINGDOM
View details

Jan Baumbach

Chair and full professor

Universität Hamburg

GERMANY
View details

paul klenerman

University of Oxford

UNITED KINGDOM
View details

Francesco Carli

Staff scientist

European Bioinformatics Institute

UNITED KINGDOM
View details

Kylie Renee James

University of New South Wales

AUSTRALIA
View details

Matthias Zilbauer

University of Cambridge

UNITED KINGDOM
View details

Michael Hartung

Universität Hamburg

GERMANY
View details

Alexander Predeus

Principal bioinformatician

Wellcome Sanger Institute

UNITED KINGDOM
View details

Judith AH Wodke

University Medicine Greifswald

GERMANY
View details

Stefan Bonn

Professor, Institute Director

-

GERMANY
View details

Tomáš Helikar

Eberhard Professor

University of Nebraska - Lincoln

UNITED STATES
View details

Simon Koplev

Assistant Professor at KTH Royal Institute of Technology

KTH Royal Institute of Technology

SWEDEN
View details

Malte Benedikt Kuehl

Aarhus University

DENMARK
View details

Barbara Zdrazil

Universität Wien

AUSTRIA
View details